1-47416333-CATGG-C
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_012186.3(FOXE3):c.21_24delGGAT(p.Met7IlefsTer216) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000327 in 1,222,594 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_012186.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000152 AC: 1AN: 65918Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 38302
GnomAD4 exome AF: 0.00000327 AC: 4AN: 1222594Hom.: 0 AF XY: 0.00000333 AC XY: 2AN XY: 600326
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital primary aphakia;C1862839:Anterior segment dysgenesis Pathogenic:1
This sequence change creates a premature translational stop signal (p.Met7Ilefs*216) in the FOXE3 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 313 amino acid(s) of the FOXE3 protein. This variant is present in population databases (no rsID available, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with autosomal recessive FOXE3-related conditions (PMID: 19708017, 25504734, 26995144). ClinVar contains an entry for this variant (Variation ID: 1077103). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects FOXE3 function (PMID: 25504734). This variant disrupts a region of the FOXE3 protein in which other variant(s) (p.Cys240*) have been determined to be pathogenic (PMID: 16826526, 20140963, 24033328). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Congenital primary aphakia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at